bioAffinity Technologies, Inc. (BIAF)
2.15
+0.22
(+11.40%)
USD |
NASDAQ |
Nov 18, 16:00
2.08
-0.07
(-3.26%)
After-Hours: 20:00
bioAffinity Technologies Total Liabilities (Quarterly) : 3.639M for Sept. 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 3.639M |
| June 30, 2026 | 3.850M |
| March 31, 2026 | 4.284M |
| December 31, 2025 | 3.683M |
| September 30, 2025 | 2.644M |
| June 30, 2025 | 6.887M |
| March 31, 2025 | 4.108M |
| December 31, 2024 | 3.912M |
| September 30, 2024 | 3.431M |
| June 30, 2024 | 3.223M |
| March 31, 2024 | 2.792M |
| December 31, 2023 | 3.366M |
| Date | Value |
|---|---|
| September 30, 2023 | 3.196M |
| June 30, 2023 | 0.7752M |
| March 31, 2023 | 0.7963M |
| December 31, 2022 | 1.139M |
| September 30, 2022 | 1.464M |
| June 30, 2022 | 13.68M |
| March 31, 2022 | 14.03M |
| December 31, 2021 | 13.20M |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | 11.17M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Anika Therapeutics, Inc. | 52.02M |
| Perspective Therapeutics, Inc. | 71.00M |
| MiMedx Group, Inc. | 53.47M |
| Veracyte, Inc. | 139.99M |
| T2 Biosystems, Inc. | -- |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 7.554M |
| Shareholders Equity (Quarterly) | 3.915M |
| Debt to Equity Ratio | 0.3827 |
| Current Ratio | 1.511 |
| Net Debt Paydown Yield | -2.16% |